Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
This study has been completed.
Sponsor:
DynPort Vaccine Company LLC, A CSC Company
Information provided by (Responsible Party):
DynPort Vaccine Company LLC, A CSC Company
ClinicalTrials.gov Identifier:
NCT00764634
First received: September 30, 2008
Last updated: November 28, 2011
Last verified: November 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2010 |
| Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | June 29, 2011 |